Health Catalyst, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Health Catalyst, Inc. on July 29, 2021. The report addresses a corporate governance amendment approved by the Board of Directors effective immediately on the date of the report.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.
Material Changes
The Board approved an amendment to the Company's amended and restated bylaws. The key changes include:
- Designation of federal district courts as the exclusive jurisdiction for any litigation arising under the Securities Act of 1933.
- Provisions stating that any person or entity acquiring an interest in the Company's capital stock is deemed to have notice of and consented to the exclusive jurisdiction provision.
Management Commentary and Rationale
Management stated the amendment was approved to reduce potential expenses the Company may incur if required to defend specified actions or proceedings in multiple jurisdictions or in parallel proceedings in federal and state courts simultaneously.
Key Facts for Investor Verification
- Verify the effective date of the bylaw amendment (July 29, 2021).
- Confirm the scope of the exclusive federal jurisdiction provision (limited to Securities Act of 1933 litigation).
- Review the full text of Exhibit 3.1 for the complete amended bylaws.